AnaptysBio, Inc. (ANAB)
46.24
-4.02
(-8.00%)
USD |
NASDAQ |
Jan 15, 16:00
46.42
+0.18
(+0.39%)
After-Hours: 20:00
AnaptysBio SG&A Expense (TTM): 45.14M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 214.26M |
| Ovid Therapeutics, Inc. | 22.56M |
| Ionis Pharmaceuticals, Inc. | 351.68M |
| CorMedix, Inc. | 75.56M |
| Verastem, Inc. | 67.48M |